155 related articles for article (PubMed ID: 37091377)
1. Total Chemical Synthesis of Palmitoyl-Conjugated Insulin.
Liu M; Li Q; Delaine C; Wu H; Arsenakis Y; White BF; Forbes BE; Chandrashekar C; Hossain MA
ACS Omega; 2023 Apr; 8(15):13715-13720. PubMed ID: 37091377
[TBL] [Abstract][Full Text] [Related]
2. Acylation of human insulin with palmitic acid extends the time action of human insulin in diabetic dogs.
Myers SR; Yakubu-Madus FE; Johnson WT; Baker JE; Cusick TS; Williams VK; Tinsley FC; Kriauciunas A; Manetta J; Chen VJ
Diabetes; 1997 Apr; 46(4):637-42. PubMed ID: 9075804
[TBL] [Abstract][Full Text] [Related]
3. Basal activity profiles of NPH and [Nepsilon-palmitoyl Lys (B29)] human insulins in subjects with IDDM.
Radziuk J; Pye S; Bradley B; Braaten J; Vignati L; Roach P; Bowsher R; DiMarchi R; Chance R
Diabetologia; 1998 Jan; 41(1):116-20. PubMed ID: 9498640
[TBL] [Abstract][Full Text] [Related]
4. Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs.
Markussen J; Havelund S; Kurtzhals P; Andersen AS; Halstrøm J; Hasselager E; Larsen UD; Ribel U; Schäffer L; Vad K; Jonassen I
Diabetologia; 1996 Mar; 39(3):281-8. PubMed ID: 8721773
[TBL] [Abstract][Full Text] [Related]
5. [The becoming of reactions of lipolysis in phylogenesis. The palmitic and oleic triglycerides as substrates. Insulin, condition of normolipemia and formation of hyper lipoproteinemia type IIb, IV and V].
Titov VN; Rozhkova TA; Aripovsky AV; Amelyushkina VA; Karganov MY
Klin Lab Diagn; 2018; 63(1):4-15. PubMed ID: 30550084
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and purification of NB1-palmitoyl insulin.
Tsai YJ; Rottero A; Chow DD; Hwang KJ; Lee VH; Zhu G; Chan KK
J Pharm Sci; 1997 Nov; 86(11):1264-8. PubMed ID: 9383737
[TBL] [Abstract][Full Text] [Related]
7. Insulin degludec. Uncertainty over cardiovascular harms.
Prescrire Int; 2014 Jun; 23(150):149. PubMed ID: 25121146
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness and harms of long-acting insulins for type 1 and type 2 diabetes: A systematic review and meta-analysis.
Holmes RS; Crabtree E; McDonagh MS
Diabetes Obes Metab; 2019 Apr; 21(4):984-992. PubMed ID: 30552792
[TBL] [Abstract][Full Text] [Related]
9. Perturbation of insulin-receptor interactions by intramolecular hormone cross-linking. Analysis of relative movement among residues A1, B1, and B29.
Nakagawa SH; Tager HS
J Biol Chem; 1989 Jan; 264(1):272-9. PubMed ID: 2642474
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological properties of insulin-deoxycholic acid chemical conjugates.
Lee S; Kim K; Kumar TS; Lee J; Kim SK; Lee DY; Lee YK; Byun Y
Bioconjug Chem; 2005; 16(3):615-20. PubMed ID: 15898729
[TBL] [Abstract][Full Text] [Related]
11. [The evaluation of unsaturation of blood lipids using methods of physical chemistry and clinical biochemistry. The insulin regulation of metabolism of fatty acids, number of double binds and cell absorption of glucose].
Titov VN; Sajina NN; Aripovskii AV; Evteieva NM; Tibilova OA; Kukharchuk VV
Klin Lab Diagn; 2016 Apr; 61(4):196-204. PubMed ID: 30586235
[TBL] [Abstract][Full Text] [Related]
12. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
Hemmingsen B; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Tolerability of Insulin Degludec Versus Other Long-acting Basal Insulin Analogues in the Treatment of Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.
Dong ZY; Feng JH; Zhang JF
Clin Ther; 2022 Nov; 44(11):1520-1533. PubMed ID: 36763996
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of insulin analogues therapeutically available to patients.
Adams GG; Meal A; Morgan PS; Alzahrani QE; Zobel H; Lithgo R; Kok MS; Besong DTM; Jiwani SI; Ballance S; Harding SE; Chayen N; Gillis RB
PLoS One; 2018; 13(3):e0195010. PubMed ID: 29596514
[TBL] [Abstract][Full Text] [Related]
15. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
16. Insulin degludec: a long-acting modern insulin analogue with a predictable pharmacokinetic/pharmacodynamic profile.
Rendell M
Drugs Today (Barc); 2013 Jun; 49(6):387-97. PubMed ID: 23807942
[TBL] [Abstract][Full Text] [Related]
17. Structural effects of protein lipidation as revealed by LysB29-myristoyl, des(B30) insulin.
Olsen HB; Kaarsholm NC
Biochemistry; 2000 Oct; 39(39):11893-900. PubMed ID: 11009601
[TBL] [Abstract][Full Text] [Related]
18. Development of a process to manufacture PEGylated orally bioavailable insulin.
Hazra P; Adhikary L; Dave N; Khedkar A; Manjunath HS; Anantharaman R; Iyer H
Biotechnol Prog; 2010; 26(6):1695-704. PubMed ID: 20949602
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action in dogs of slow-acting insulin analog O346.
Ellmerer M; Hamilton-Wessler M; Kim SP; Dea MK; Kirkman E; Perianayagam A; Markussen J; Bergman RN
J Clin Endocrinol Metab; 2003 May; 88(5):2256-62. PubMed ID: 12727983
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
